Rainbow Childrens Medicare Ltd
Rainbow Children's Medicare Limited operates a multi-specialty pediatric, obstetrics, and gynecology hospital chain in India. The company offers a wide range of services such as newborn and pediatric intensive care, pediatric multi-specialty services, pediatric quaternary care, obstetrics, and gynecology. [1] It is country’s largest pediatric hospital chain with 16 hospitals spread across 6 cities.[2]
- Market Cap ₹ 11,403 Cr.
- Current Price ₹ 1,123
- High / Low ₹ 1,646 / 1,090
- Stock P/E 46.5
- Book Value ₹ 156
- Dividend Yield 0.27 %
- ROCE 18.3 %
- ROE 16.7 %
- Face Value ₹ 10.0
Pros
- Company's median sales growth is 20.5% of last 10 years
- Company's working capital requirements have reduced from 47.7 days to 19.5 days
Cons
- Stock is trading at 7.20 times its book value
* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.
Peer comparison
Healthcare Healthcare Healthcare Services Hospital
Part of BSE 500 BSE Healthcare Nifty 500 BSE Allcap BSE 250 SmallCap Index
Quarterly Results
Standalone Figures in Rs. Crores / View Consolidated
Profit & Loss
Standalone Figures in Rs. Crores / View Consolidated
| Mar 2015 | Mar 2016 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | TTM | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 148 | 234 | 402 | 543 | 695 | 614 | 925 | 1,114 | 1,237 | 1,455 | 1,492 | |
| 110 | 204 | 332 | 430 | 486 | 449 | 626 | 729 | 820 | 976 | 1,010 | |
| Operating Profit | 39 | 30 | 70 | 112 | 209 | 166 | 299 | 385 | 417 | 479 | 482 |
| OPM % | 26% | 13% | 17% | 21% | 30% | 27% | 32% | 35% | 34% | 33% | 32% |
| 10 | 16 | 10 | 8 | 12 | 12 | 21 | 27 | 37 | 49 | 52 | |
| Interest | 2 | 3 | 4 | 6 | 46 | 44 | 53 | 55 | 59 | 74 | 70 |
| Depreciation | 7 | 18 | 28 | 36 | 65 | 68 | 77 | 84 | 105 | 132 | 133 |
| Profit before tax | 40 | 24 | 47 | 79 | 109 | 66 | 190 | 273 | 289 | 322 | 330 |
| Tax % | 33% | 28% | 22% | 25% | 35% | 25% | 25% | 25% | 26% | 26% | |
| 27 | 17 | 36 | 60 | 71 | 49 | 142 | 206 | 215 | 238 | 245 | |
| EPS in Rs | 28.65 | 18.39 | 8.30 | 13.56 | 16.12 | 11.24 | 15.13 | 20.28 | 21.17 | 23.40 | 24.14 |
| Dividend Payout % | 7% | 11% | 12% | 7% | 12% | 0% | 13% | 15% | 14% | 13% |
| Compounded Sales Growth | |
|---|---|
| 10 Years: | 26% |
| 5 Years: | 16% |
| 3 Years: | 16% |
| TTM: | 5% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | 24% |
| 5 Years: | 27% |
| 3 Years: | 18% |
| TTM: | 5% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | % |
| 5 Years: | % |
| 3 Years: | 16% |
| 1 Year: | -19% |
| Return on Equity | |
|---|---|
| 10 Years: | % |
| 5 Years: | 19% |
| 3 Years: | 19% |
| Last Year: | 17% |
Balance Sheet
Standalone Figures in Rs. Crores / View Consolidated
| Mar 2015 | Mar 2016 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Sep 2025 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Equity Capital | 9 | 9 | 44 | 44 | 44 | 44 | 94 | 102 | 102 | 102 | 102 |
| Reserves | 170 | 272 | 304 | 359 | 371 | 421 | 531 | 987 | 1,184 | 1,387 | 1,482 |
| 11 | 24 | 24 | 61 | 480 | 495 | 559 | 538 | 735 | 734 | 727 | |
| 31 | 40 | 73 | 91 | 117 | 109 | 101 | 132 | 130 | 131 | 168 | |
| Total Liabilities | 221 | 346 | 445 | 555 | 1,012 | 1,070 | 1,285 | 1,759 | 2,150 | 2,354 | 2,478 |
| 54 | 123 | 293 | 333 | 663 | 722 | 813 | 891 | 1,219 | 1,368 | 1,352 | |
| CWIP | 30 | 28 | 12 | 21 | 43 | 29 | 6 | 23 | 20 | 28 | 52 |
| Investments | 24 | 2 | 0 | 5 | 24 | 37 | 42 | 105 | 346 | 596 | 606 |
| 113 | 193 | 140 | 197 | 282 | 282 | 424 | 740 | 566 | 362 | 469 | |
| Total Assets | 221 | 346 | 445 | 555 | 1,012 | 1,070 | 1,285 | 1,759 | 2,150 | 2,354 | 2,478 |
Cash Flows
Standalone Figures in Rs. Crores / View Consolidated
| Mar 2015 | Mar 2016 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | |
|---|---|---|---|---|---|---|---|---|---|---|
| 23 | 17 | 48 | 96 | 178 | 142 | 214 | 315 | 306 | 385 | |
| -21 | -107 | -42 | -125 | -123 | -87 | -169 | -460 | -214 | -263 | |
| -4 | 92 | -7 | 31 | -54 | -56 | -41 | 148 | -97 | -113 | |
| Net Cash Flow | -1 | 2 | -2 | 2 | 1 | -2 | 4 | 2 | -4 | 9 |
Ratios
Standalone Figures in Rs. Crores / View Consolidated
| Mar 2015 | Mar 2016 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Debtor Days | 11 | 10 | 14 | 19 | 19 | 27 | 16 | 19 | 21 | 20 |
| Inventory Days | 39 | 35 | 36 | 32 | 52 | 35 | 27 | 43 | 52 | 44 |
| Days Payable | 130 | 107 | 148 | 153 | 152 | 190 | 115 | 195 | 177 | 165 |
| Cash Conversion Cycle | -80 | -62 | -97 | -102 | -80 | -128 | -72 | -133 | -104 | -102 |
| Working Capital Days | -24 | -34 | -30 | -5 | 1 | 5 | -14 | 80 | 44 | 19 |
| ROCE % | 7% | 20% | 23% | 12% | 23% | 24% | 19% | 18% |
Documents
Announcements
- Announcement under Regulation 30 (LODR)-Earnings Call Transcript 19h
- Announcement under Regulation 30 (LODR)-Newspaper Publication 29 Jan
-
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome
29 Jan - Audio recording of Q3 & 9M FY26 earnings call posted (Jan 29, 2026).
-
Announcement under Regulation 30 (LODR)-Investor Presentation
28 Jan - Earnings Presentation on Unaudited Financial Results (Standalone and Consolidated) for the Quarter and Nine months ended December 31, 2025.
-
Announcement under Regulation 30 (LODR)-Press Release / Media Release
28 Jan - Q3 FY26 revenue Rs4,454Mn; commissioned Rajahmundry (100 beds) and Electronic City (~90); Abrarali Dalal appointed CEO.
Annual reports
Concalls
-
Feb 2026Transcript PPT REC
-
Nov 2025Transcript PPT REC
-
Aug 2025Transcript PPT REC
-
May 2025Transcript PPT
-
Feb 2025Transcript PPT
-
Nov 2024Transcript PPT
-
Aug 2024Transcript PPT REC
-
May 2024Transcript PPT
-
Feb 2024Transcript PPT
-
Nov 2023Transcript PPT REC
-
Aug 2023Transcript PPT
-
May 2023Transcript PPT
-
Feb 2023Transcript PPT
-
Nov 2022TranscriptPPT
-
Nov 2022Transcript PPT
-
Aug 2022Transcript PPT
-
Aug 2022TranscriptAI SummaryPPT
-
Jun 2022Transcript PPT
Business Overview[1]
The company operates 22 hospitals and 5 clinics across 9 cities, with a total bed capacity of 2,285. It specializes in pediatric healthcare under "Rainbow Children's Hospital" and women's healthcare under "Birthright by Rainbow."